Immunogenicity 11787
Sample ID
3784
Response
Negative
Tumor Type
Melanoma
Gene Symbol
SERINC2
Transcript ID
uc009vtw.1
HLA INFO
A*03:01
TCR INFO
No TCR info found!
Full length protein sequence (206 aa)
MGACL
1
GACSL
6
LSCAS
11
CLCGS
16
APCIL
21
CSCCP
26
ASRNS
31
TVSRL
36
IFTFF
41
LFLGV
46
LVSII
51
MLSPG
56
VESQL
61
YKLPW
66
VCEEG
71
AGIPT
76
VLQGH
81
IDCGS
86
LLGYR
91
AVYRM
96
CFATA
101
AFFFF
106
FTLLM
111
LCVSS
116
SRDPR
121
AAIQN
126
GLVLL
131
RRRGL
136
LPLHP
141
HPAGA
146
AHRLC
151
ALLEP
156
AVAGQ
161
GRGVR
166
FPCLV
171
RRSVL
176
PPCLR
181
VGTRA
186
WAGLG
191
LPEKS
196
RVLEA
201
R
206
Mutation Information
DNA mutation:
None
Peptide Range:
131 ~ 155
Mut AA position:
143 (13 in Wild Type peptide)
Alignment
Wild Type:
"GLVLLRRRGLLPLHPHPAGAAHRLC
||||||||||||.||||||||||||
Mutant:
GLVLLRRRGLLPFHPHPAGAAHRLC"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) SERINC2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay